Immune Mechanisms Induced by Sublingual Immunotherapy in Allergic Respiratory Diseases

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2022 Aug 17

PMID 35975953

Authors

Umut Gazi

Nerin Nadir Bahceciler

Affiliations

Soon will be listed here.

Abstract

Allergic respiratory diseases (ARDs) are still a major burden on global public health. Sublingual immunotherapy (SLIT) is a mode of allergen immunotherapy (AIT) which involves administration of the allergen under the tongue, and benefits from tolerogenic properties of the oral mucosa. Studies revealed reduced levels of eosinophilia and eosinophil-dominated inflammation in airways of both animals and humans after SLIT. SLIT was also suggested to lower basophil responsiveness and innate lymphoid cell-2 function in blood samples collected from patients with ARD. Moreover, apart from shifting pathogenic type 2 (TH2) to a type 1 (TH1) and protective regulatory (Treg) polarization of helper T-cell immune response, antibody isotype switch from IgE to IgG1, IgG2, IgG4 and IgA was also reported in patients with ARD receiving SLIT. Today, the literature on SLIT-mediated activities is still scarce and more studies are required to further enlighten the mechanisms utilized by SLIT for the induction of tolerance. The aim of this review is to summarize the current knowledge about the immune-regulatory mechanisms induced by SLIT against ARDs.

Citing Articles

Prophylactic Peanut Allergen Ara h 6 Sublingual Immunotherapy Drives Expansion of FoxP3 Helios Regulatory T Cells in the Absence of Allergen-Specific IgA.

Larsen J, Lundsgaard E, Danneskiold-Samsoe N, Sonne S, Rigby N, Mackie A Immunology. 2025; 174(3):340-348.

PMID: 39777617 PMC: 11799393. DOI: 10.1111/imm.13883.

Deciphering Differential Behavior of Immune Responses as the Foundation for Precision Dosing in Allergen Immunotherapy.

Magnan A, Nicolas J, Caimmi D, Vocanson M, Haddad T, Colas L J Pers Med. 2023; 13(2).

PMID: 36836557 PMC: 9964800. DOI: 10.3390/jpm13020324.

Diagnosis and Management of Allergic Rhinitis in Asthmatic Children.

Tenero L, Vaia R, Ferrante G, Maule M, Venditto L, Piacentini G J Asthma Allergy. 2023; 16:45-57.

PMID: 36636703 PMC: 9829985. DOI: 10.2147/JAA.S281439.

References

Tourdot S, Airouche S, Berjont N, Moussu H, Betbeder D, Nony E . Efficacy of sublingual vectorized recombinant Bet v 1a in a mouse model of birch pollen allergic asthma. Vaccine. 2013; 31(23):2628-37. DOI: 10.1016/j.vaccine.2013.03.041. View

Hellings P, Steelant B . Epithelial barriers in allergy and asthma. J Allergy Clin Immunol. 2020; 145(6):1499-1509. PMC: 7270816. DOI: 10.1016/j.jaci.2020.04.010. View

Ghasemi Z, Varasteh A, Moghadam M, Jalali S, Anissian A, Sankian M . Sublingual Immunotherapy with Sal k1 Expressing Lactococcus lactis Down-regulates Th2 Immune Responses in Balb/c Mice. Iran J Allergy Asthma Immunol. 2018; 17(3):281-290. View

Akdis C, Arkwright P, Bruggen M, Busse W, Gadina M, Guttman-Yassky E . Type 2 immunity in the skin and lungs. Allergy. 2020; 75(7):1582-1605. DOI: 10.1111/all.14318. View

Helfrich S, Mindt B, Fritz J, Duerr C . Group 2 Innate Lymphoid Cells in Respiratory Allergic Inflammation. Front Immunol. 2019; 10:930. PMC: 6566538. DOI: 10.3389/fimmu.2019.00930. View

Bahceciler N, Galip N, Cobanoglu N . Multiallergen-specific immunotherapy in polysensitized patients: where are we?. Immunotherapy. 2013; 5(2):183-90. DOI: 10.2217/imt.12.161. View

Ventura M, Murgia N, Montuschi P, Gelardi M, Ciabattoni G, Buquicchio R . Exhaled breath condensate, nasal eosinophil cationic protein level and nasal cytology during immunotherapy for cypress allergy. J Biol Regul Homeost Agents. 2014; 27(4):1083-9. View

Akdis C, Barlan I, Bahceciler N, Akdis M . Immunological mechanisms of sublingual immunotherapy. Allergy. 2006; 61 Suppl 81:11-4. DOI: 10.1111/j.1398-9995.2006.01159.x. View

Weinfeld D, Westin U, Hellkvist L, Mellqvist U, Jacobsson I, Cardell L . A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy. Allergy Asthma Clin Immunol. 2020; 16:31. PMC: 7189556. DOI: 10.1186/s13223-020-00427-z. View

10.

Miraglia Del Giudice M, Licari A, Brambilla I, Tosca M, Ciprandi G . Allergen Immunotherapy in Pediatric Asthma: A Pragmatic Point of View. Children (Basel). 2020; 7(6). PMC: 7346201. DOI: 10.3390/children7060058. View

11.

Asano K, Ueki S, Tamari M, Imoto Y, Fujieda S, Taniguchi M . Adult-onset eosinophilic airway diseases. Allergy. 2020; 75(12):3087-3099. DOI: 10.1111/all.14620. View

12.

Celebi Sozener Z, Cevhertas L, Nadeau K, Akdis M, Akdis C . Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol. 2020; 145(6):1517-1528. DOI: 10.1016/j.jaci.2020.04.024. View

13.

Eifan A, Akkoc T, Yildiz A, Keles S, Ozdemir C, Bahceciler N . Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial. Clin Exp Allergy. 2010; 40(6):922-32. DOI: 10.1111/j.1365-2222.2009.03448.x. View

14.

. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020; 8(6):585-596. PMC: 7284317. DOI: 10.1016/S2213-2600(20)30105-3. View

15.

Hammad H, Lambrecht B . Barrier Epithelial Cells and the Control of Type 2 Immunity. Immunity. 2015; 43(1):29-40. DOI: 10.1016/j.immuni.2015.07.007. View

16.

Hagner S, Rask C, Brimnes J, Sejer Andersen P, Raifer H, Renz H . House Dust Mite-Specific Sublingual Immunotherapy Prevents the Development of Allergic Inflammation in a Mouse Model of Experimental Asthma. Int Arch Allergy Immunol. 2016; 170(1):22-34. DOI: 10.1159/000446155. View

17.

Schulten V, Tripple V, Aasbjerg K, Backer V, Lund G, Wurtzen P . Distinct modulation of allergic T cell responses by subcutaneous vs. sublingual allergen-specific immunotherapy. Clin Exp Allergy. 2015; 46(3):439-48. PMC: 4767546. DOI: 10.1111/cea.12653. View

18.

Marcucci F, Sensi L, Incorvaia C, DellAlbani I, Di Cara G, Frati F . Specific IgE response to different grass pollen allergen components in children undergoing sublingual immunotherapy. Clin Mol Allergy. 2012; 10(1):7. PMC: 3511885. DOI: 10.1186/1476-7961-10-7. View

19.

Laulajainen-Hongisto A, Lyly A, Hanif T, Dhaygude K, Kankainen M, Renkonen R . Genomics of asthma, allergy and chronic rhinosinusitis: novel concepts and relevance in airway mucosa. Clin Transl Allergy. 2020; 10(1):45. PMC: 7592594. DOI: 10.1186/s13601-020-00347-6. View

20.

Heeringa J, McKenzie C, Varese N, Hew M, Bakx A, Aui P . Induction of IgG and IgG B-cell memory following sublingual immunotherapy for ryegrass pollen allergy. Allergy. 2019; 75(5):1121-1132. PMC: 7317934. DOI: 10.1111/all.14073. View